Xiaolei Ma

Prebiotic-like cyclodextrin assisted silybin on NAFLD through restoring liver and gut homeostasis.

J. Cui, Hongliang Wang, Ya-Nan Wang, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters

Jian-Dong Jiang, Yun Zhan, Yanxing Han, 2019, Advanced Functional Materials.

Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota.

Shuwang He, J. Cui, Y. Che, 2022, Small.

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(−/−) mice

Yuhuan Li, Jiandong Jiang, Xiao‐Lei Ma, 2020, Acta pharmaceutica Sinica. B.

Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease.

Xiao‐Lei Ma, Lu‐Lu Wang, Wen-sheng Zheng, 2021, ACS nano.

Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism.

Ling Ren, Rui Li, Hao Yu, 2023, Journal of ethnopharmacology.